Literature DB >> 28431812

Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice.

Akihiro Nakatsukasa1, Koji Kuruma2, Masatoshi Okamatsu1, Takahiro Hiono1, Mizuho Suzuki1, Keita Matsuno3, Hiroshi Kida4, Takayoshi Oyamada2, Yoshihiro Sakoda5.   

Abstract

Transdermal vaccination using a microneedle (MN) confers enhanced immunity compared with subcutaneous (SC) vaccination. Here we developed a novel dissolving MN patch for the influenza vaccine. The potencies of split virion and whole virus particle (WVP) vaccines prepared from A/Puerto Rico/8/1934 (H1N1) and A/duck/Hokkaido/Vac-3/2007 (H5N1), respectively, were evaluated. MN vaccination induced higher neutralizing antibody responses than SC vaccination in mice. Moreover, MN vaccination with a lower dose of antigens conferred protective immunity against lethal challenges of influenza viruses than SC vaccination in mice. These results suggest that the WVP vaccines administered using MN are an effective combination for influenza vaccine to be further validated in humans.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dissolving microneedle; Influenza; Split virion; Transdermal vaccination; Vaccine; Whole virus particle

Mesh:

Substances:

Year:  2017        PMID: 28431812     DOI: 10.1016/j.vaccine.2017.04.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges.

Authors:  Jasmin Hassan; Charlotte Haigh; Tanvir Ahmed; Md Jasim Uddin; Diganta B Das
Journal:  Pharmaceutics       Date:  2022-05-16       Impact factor: 6.525

Review 2.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

3.  Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.

Authors:  Elena V Vassilieva; Shelly Wang; Song Li; Mark R Prausnitz; Richard W Compans
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

4.  Technology update: dissolvable microneedle patches for vaccine delivery.

Authors:  Aoife M Rodgers; Ana Sara Cordeiro; Ryan F Donnelly
Journal:  Med Devices (Auckl)       Date:  2019-09-19

5.  Oral Supplementation of the Vitamin D Metabolite 25(OH)D3 Against Influenza Virus Infection in Mice.

Authors:  Hirotaka Hayashi; Masatoshi Okamatsu; Honami Ogasawara; Naoko Tsugawa; Norikazu Isoda; Keita Matsuno; Yoshihiro Sakoda
Journal:  Nutrients       Date:  2020-07-05       Impact factor: 5.717

6.  Progress in microneedle array patch (MAP) for vaccine delivery.

Authors:  Thuy Trang Nguyen; Yujeong Oh; Yunseo Kim; Yura Shin; Seung-Ki Baek; Jung-Hwan Park
Journal:  Hum Vaccin Immunother       Date:  2020-07-15       Impact factor: 3.452

Review 7.  Microarray patches enable the development of skin-targeted vaccines against COVID-19.

Authors:  Emrullah Korkmaz; Stephen C Balmert; Tina L Sumpter; Cara Donahue Carey; Geza Erdos; Louis D Falo
Journal:  Adv Drug Deliv Rev       Date:  2021-02-02       Impact factor: 17.873

8.  Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial.

Authors:  Nadine G Rouphael; Lilin Lai; Sonia Tandon; Michele Paine McCullough; Yunchuan Kong; Sarah Kabbani; Muktha S Natrajan; Yongxian Xu; Yerun Zhu; Dongli Wang; Jesse O'Shea; Amy Sherman; Tianwei Yu; Sebastien Henry; Devin McAllister; Daniel Stadlbauer; Surender Khurana; Hana Golding; Florian Krammer; Mark J Mulligan; Mark R Prausnitz
Journal:  NPJ Vaccines       Date:  2021-07-14       Impact factor: 7.344

Review 9.  Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application.

Authors:  Ana Sara Cordeiro; Yogita Patil-Sen; Maitreyi Shivkumar; Ronak Patel; Abdulwahhab Khedr; Mohamed A Elsawy
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.